Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
As of close of business last night, Tenet Healthcare Corp’s stock clocked out at $208.62, down -0.25% from its previous closing price of $209.14. In other words, the price has decreased by -$0.25 from its previous closing price. On the day, 1.23 million shares were traded. THC stock price reached its highest trading level at $214.38 during the session, while it also had its lowest trading level at $207.47.
Ratios:
To gain a deeper understanding of THC’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.16 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 12.21. For the most recent quarter (mrq), Quick Ratio is recorded 1.64 and its Current Ratio is at 1.71. In the meantime, Its Debt-to-Equity ratio is 3.29 whereas as Long-Term Debt/Eq ratio is at 3.26.
Wells Fargo Upgraded its Equal Weight to Overweight on May 29, 2025, while the target price for the stock was maintained at $195.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Oct 29 ’25 when FISHER RICHARD W bought 2,500 shares for $208.43 per share.
Sutaria Saumya sold 78,762 shares of THC for $15,026,139 on Sep 10 ’25. The CEO now owns 368,683 shares after completing the transaction at $190.78 per share. On Sep 10 ’25, another insider, Sutaria Saumya, who serves as the Officer of the company, bought 78,762 shares for $190.78 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, THC now has a Market Capitalization of 18334568448 and an Enterprise Value of 33232568320. As of this moment, Tenet’s Price-to-Earnings (P/E) ratio for their current fiscal year is 14.30, and their Forward P/E ratio for the next fiscal year is 12.73. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.92. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.88 while its Price-to-Book (P/B) ratio in mrq is 4.57. Its current Enterprise Value per Revenue stands at 1.594 whereas that against EBITDA is 7.433.
Stock Price History:
The Beta on a monthly basis for THC is 1.52, which has changed by 0.33619416 over the last 52 weeks, in comparison to a change of 0.19088471 over the same period for the S&P500. Over the past 52 weeks, THC has reached a high of $217.43, while it has fallen to a 52-week low of $109.82. The 50-Day Moving Average of the stock is 6.84%, while the 200-Day Moving Average is calculated to be 30.31%.
Shares Statistics:
It appears that THC traded 1.08M shares on average per day over the past three months and 1244620 shares per day over the past ten days. A total of 87.87M shares are outstanding, with a floating share count of 86.81M. Insiders hold about 1.23% of the company’s shares, while institutions hold 98.32% stake in the company. Shares short for THC as of 1760486400 were 2546243 with a Short Ratio of 2.36, compared to 1757894400 on 2517761. Therefore, it implies a Short% of Shares Outstanding of 2546243 and a Short% of Float of 3.8699999999999997.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0. The stock’s 5-year Average Dividend Yield is 2.75. The current Payout Ratio is 0.00% for THC, which recently paid a dividend on 2000-03-13 with an ex-dividend date of 2000-03-13. Stock splits for the company last occurred on 2012-10-11 when the company split stock in a 1:4 ratio.
Earnings Estimates
. The current market rating for Tenet Healthcare Corp (THC) reflects the collective analysis of 16.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is $4.41, with high estimates of $4.86 and low estimates of $3.82.
Analysts are recommending an EPS of between $16.33 and $15.77 for the fiscal current year, implying an average EPS of $16.05. EPS for the following year is $16.38, with 19.0 analysts recommending between $17.77 and $14.0.
Revenue Estimates
In. The current quarter, 16 analysts expect revenue to total $5.45B. It ranges from a high estimate of $5.52B to a low estimate of $5.36B. As of. The current estimate, Tenet Healthcare Corp’s year-ago sales were $5.07BFor the next quarter, 16 analysts are estimating revenue of $5.44B. There is a high estimate of $5.51B for the next quarter, whereas the lowest estimate is $5.33B.
A total of 18 analysts have provided revenue estimates for THC’s current fiscal year. The highest revenue estimate was $21.5B, while the lowest revenue estimate was $21.06B, resulting in an average revenue estimate of $21.24B. In the same quarter a year ago, actual revenue was $20.66BBased on 18 analysts’ estimates, the company’s revenue will be $22.15B in the next fiscal year. The high estimate is $22.55B and the low estimate is $21.6B.
